Palmitoylethanolamide (PEA)
An endogenous fatty acid amide your body already makes in response to tissue damage. One of the better-evidenced pain supplements, and almost nobody has heard of it.
How Palmitoylethanolamide (PEA) actually works
An endogenous fatty acid amide that acts primarily through PPAR-alpha, downregulating mast-cell degranulation and glial activation. It is not a cannabinoid but it potentiates endocannabinoid signalling by competing for the enzymes that degrade anandamide. The target is neuroinflammation specifically rather than nociception.
Palmitoylethanolamide (PEA) quick facts
| Suggested dose | 600–1,200 mg daily of MICRONISED or ultramicronised PEA. Effects typically build over 2–4 weeks. |
| How often | Daily |
| Who it's for | Chronic neuropathic or inflammatory pain, especially where NSAIDs are not an option. |
✅ Clinically validated
- Meta-analyses of RCTs show clinically meaningful reductions in chronic pain scores, with a number-needed-to-treat around 1.7 in some analyses — a strong figure for any pain intervention.
- Trials support benefit in sciatica, diabetic neuropathy, carpal tunnel and fibromyalgia.
- Adverse event rates are consistently no different from placebo across trials — unusual in the pain literature.
📊 Correlative data
- Occurs naturally in egg yolk, peanuts and soy lecithin, and was first identified because those foods showed anti-inflammatory activity. Levels in human tissue rise at sites of injury and inflammation, which is an observational finding about endogenous production rather than about intake.
🧪 Theoretical / extrapolated benefits
- A PPAR-alpha agonist that downregulates mast cell and glial activation. It also potentiates endocannabinoids indirectly via the 'entourage effect', without binding CB receptors itself.
These tiers tell you how much human evidence exists — not how well something works. This is the research space, and most of what’s in here is new rather than disproven. Something sitting at “theoretical” usually means nobody has funded the trial, not that the trial was run and failed.
The trap runs the other way too: something can be clinically validated and still do very little for you specifically. A statistically significant result in a study population is not a promise about your body.
- ✅ Clinically validated — human randomised trials or meta-analyses support it. The strongest footing available.
- 📊 Correlative — observational or epidemiological data. Suggestive, and genuinely useful for direction, but it cannot establish cause.
- 🧪 Theoretical / mechanistic — the mechanism is understood and often demonstrated in cells or animals, and the human trial doesn’t exist yet. Unproven is not the same as ineffective. Plenty of what’s standard practice today sat here five years ago.
✗ is a safety flag, not a grade. Where you see it, the concern is harm — not a disappointing trial. A compound tested for one purpose and found not to help there can still be worth studying somewhere else, so a negative result never gets rendered as a cross. It sits alongside the tier, because something can be both well-studied and genuinely risky.
My job is to tell you which one you’re looking at, and let you make the call. Grading something low isn’t me dismissing it — it’s me refusing to oversell it. This is the research space, and being able to reason forward from a mechanism matters as much as waiting for the trial.
Solid trial evidence in chronic and neuropathic pain, with a remarkably clean safety profile and essentially no known drug interactions — an unusual combination. Increasing interest in post-viral cognitive symptoms on the glial mechanism. Micronised or ultramicronised forms are what the trials used; the plain form is poorly absorbed enough that the distinction matters.
Palmitoylethanolamide (PEA) — safety & side effects
- Among the best-tolerated things in this catalogue — trials consistently report side-effect rates no different from placebo. Mild GI upset is the only common report.
- No significant drug interactions identified.
- Long-term safety has not been characterised — the trials run weeks to months, not years. That is a real limit on what anyone can tell you about daily use for a decade. That is the only real caveat.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
Where to get Palmitoylethanolamide (PEA)
Find Palmitoylethanolamide (PEA) on iHerb →Get the complete breakdown for Palmitoylethanolamide (PEA) — inside the Academy alongside the full interactive Vault.
Unlock in the Academy — $10/mo →- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Coach Cam's stacks and notes
Get the complete breakdown for Palmitoylethanolamide (PEA) — inside the Academy alongside the full interactive Vault.
Unlock in the Academy — $10/mo →Bloodwork to run alongside Palmitoylethanolamide (PEA)
Run these before you start, and again after 8–12 weeks. A baseline you didn’t take is one you can never go back for.
| Marker | What it’s watching for |
|---|---|
| TSH (Thyroid-Stimulating Hormone) | Thyroid disease imitates every cognitive complaint there is |
| Vitamin B12 | Deficiency causes fog long before it causes anaemia |
| Methylmalonic Acid (MMA) | Catches the deficiency a normal B12 hides |
| Ferritin | Low iron flattens cognition at levels most labs call fine |
| Vitamin D (25-Hydroxy) | Commonly low, cheap to correct, associated with mood |
The Brain Fog & Cognition panel covers these in one order — 12 markers, $233.06 with the discount applied.
Check results you already have → · All 102 markers A–Z
Palmitoylethanolamide (PEA) — frequently asked questions
What is Palmitoylethanolamide (PEA)?
An endogenous fatty acid amide your body already makes in response to tissue damage. One of the better-evidenced pain supplements, and almost nobody has heard of it.
What is the suggested dose of Palmitoylethanolamide (PEA)?
600–1,200 mg daily of MICRONISED or ultramicronised PEA. Effects typically build over 2–4 weeks. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find Palmitoylethanolamide (PEA) dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside the Academy is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy Palmitoylethanolamide (PEA)?
Coach Cam sources Palmitoylethanolamide (PEA) from vetted, top-rated brands on iHerb — use the buy link on this page.
Build your foundation with Coach Cam
The full Supplement Vault — 350 products across 14 categories with clinical, correlative & theoretical evidence, plus my Thorne partner links — lives inside the Academy alongside 237 peptides.
Join the Academy — $10/mo →What Palmitoylethanolamide (PEA) is used for
Palmitoylethanolamide (PEA) appears under 5 goals in the Vault’s goal router, grouped by the mechanism it works through rather than by how much trial evidence exists. Each link opens that pathway in full, with the alternatives beside it and the bloodwork that tests it.